Samsonov MIu

1.3k total citations
70 papers, 897 citations indexed

About

Samsonov MIu is a scholar working on Rheumatology, Molecular Biology and Immunology. According to data from OpenAlex, Samsonov MIu has authored 70 papers receiving a total of 897 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Rheumatology, 14 papers in Molecular Biology and 13 papers in Immunology. Recurrent topics in Samsonov MIu's work include Rheumatoid Arthritis Research and Therapies (13 papers), Systemic Lupus Erythematosus Research (9 papers) and Autoimmune and Inflammatory Disorders Research (7 papers). Samsonov MIu is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (13 papers), Systemic Lupus Erythematosus Research (9 papers) and Autoimmune and Inflammatory Disorders Research (7 papers). Samsonov MIu collaborates with scholars based in Russia, United States and Austria. Samsonov MIu's co-authors include Masahiro Sokabe, Е. Л. Насонов, Hiroaki Hirata, Gilbert Reibnegger, E L Nassonov, Eugen Feist, Saeed Fatenejad, Gernot P. Tilz, Dietmar Fuchs and H. Wächter and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Samsonov MIu

60 papers receiving 869 citations

Peers

Countries citing papers authored by Samsonov MIu

Since Specialization

Citations

This map shows the geographic impact of Samsonov MIu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samsonov MIu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samsonov MIu more than expected).

Fields of papers citing papers by Samsonov MIu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samsonov MIu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samsonov MIu. The network helps show where Samsonov MIu may publish in the future.

Co-authorship network of co-authors of Samsonov MIu

This figure shows the co-authorship network connecting the top 25 collaborators of Samsonov MIu. A scholar is included among the top collaborators of Samsonov MIu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samsonov MIu. Samsonov MIu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Analysis of the Main Directions in the Development of Mono and Combination Pharmacotherapy Acting on Hormonal Signaling Pathways of Breast Cancer According to the FDA Databases and Clinicaltrials.gov 2025 ·Current Medicinal Chemistry ·(unknown), (unknown), (unknown), (unknown), Маргарита Е. Неганова, Junqi Liu, Samsonov MIu, А. В. Самородов, Е. А. Smolyarchuk, Olga Sukocheva, Vladimir N. Chubarev	3
2	Olokizumab plus methotrexate: safety and efficacy over 106 weeks of treatment 2024 ·Annals of the Rheumatic Diseases ·Eugen Feist, Roy Fleischmann, Saeed Fatenejad, (unknown), (unknown), (unknown), Michael E. Luggen, (unknown), Samsonov MIu, Josef S Smolen	3
3	Results of a 24-week open-label phase II study of olokizumab in adolescent patients with polyarticular juvenile idiopathic arthritis 2024 ·Voprosy praktičeskoj pediatrii ·Е.I. Alexeeva, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Alina N. Egorova, (unknown), (unknown), (unknown), Samsonov MIu, (unknown), И. П. Никишина, Mikhail M. Kostik	0
4	Interleukin-1 Blockade With RPH-104 (Goflikicept) in Patients With ST-Segment Elevation Myocardial Infarction: Secondary End Points From an International, Double-Blind, Randomized, Placebo-Controlled, Phase 2a Study 2024 ·Journal of Cardiovascular Pharmacology ·Antonio Abbate, Benjamín Van Tassell, Vladimir Bogin, Roshanak Markley, (unknown), Paul Cremer, I. Meray, Dmitry V. Privalov, Angela M. Taylor, (unknown), Alina N. Egorova, (unknown), Yan Lavrovsky, Samsonov MIu	7
5	Inflammation‐mediated drug interactions of olokizumab and cytochrome P450 activities in patients with rheumatoid arthritis 2024 ·British Journal of Clinical Pharmacology ·(unknown), (unknown), Diane R. Mould, (unknown), (unknown), Samsonov MIu	2
6	Targeting inerleukin-6 for renoprotection 2024 ·Frontiers in Immunology ·Ekaterina O. Gubernatorova, Samsonov MIu, Marina S. Drutskaya, (unknown), (unknown), (unknown), Kerim Mutig	1
7	Molecular mechanisms of wound healing: the role of zinc as an essential microelement 2023 ·Research Results in Pharmacology ·(unknown), (unknown), Samsonov MIu, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Т. А. Демура	9
8	BIOEQUIVALENCE STUDY OF GENERIC MOLNUPIRAVIR IN HEALTHY VOLUNTEERS 2023 ·Pharmacy & Pharmacology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Samsonov MIu, (unknown), (unknown)	0
9	Treatment of Idiopathic Recurrent Pericarditis With Goflikicept 2023 ·Journal of the American College of Cardiology ·(unknown), (unknown), О. М. Моисеева, (unknown), (unknown), Yan Lavrovsky, Antonio Abbate, (unknown), Alina N. Egorova, (unknown), Samsonov MIu	38
10	CHARACTERISTICS OF OLOKIZUMAB PHARMACOKINETICS IN PATIENTS WITH NOVEL CORONAVIRUS INFECTION COVID-19 2022 ·Pharmacy & Pharmacology ·(unknown), (unknown), (unknown), (unknown), (unknown), Diane R. Mould, Kiyonori Ito, (unknown), (unknown), (unknown), (unknown), (unknown), Samsonov MIu	0
11	Narlaprevir, ritonavir, and sofosbuvir in non-cirrhotic chronic hepatitis C genotype 1 infected patients 2020 ·(unknown), (unknown), (unknown), Vladimir Chulanov, Д. А. Гусев, Isakov Va, К. В. Жданов, (unknown), Svetlana Kizhlo, (unknown), К. В. Козлов, (unknown), (unknown), (unknown), (unknown), (unknown), Samsonov MIu, (unknown), (unknown)	0
12	Efficacy and safety of 8-week combination therapy for chronic hepatitis C with protease inhibitor narlaprevir 2020 ·Д. А. Гусев, (unknown), (unknown), Isakov Va, (unknown), К. В. Жданов, Svetlana Kizhlo, К. В. Козлов, (unknown), (unknown), (unknown), (unknown), Samsonov MIu, (unknown)	0
13	Planar compression of extracellular substrates induces S phase arrest via ATM-independent CHK2 activation 2018 ·Biochemical and Biophysical Research Communications ·Kimihide Hayakawa, Hiroaki Hirata, Samsonov MIu, Masahiro Sokabe	3
14	Pharmacokinetics of Fimasartan, a novel angiotensin II receptor type 1 antagonist in Russian population 2016 ·Arterial’naya Gipertenziya (Arterial Hypertension) ·Ж. Д. Кобалава, Yu. V. Kotovskaya, (unknown), (unknown), (unknown), Samsonov MIu, (unknown), А. О. Конради	1
15	Cardiac troponin and β-type myosin heavy chain concentrations in patients with polymyositis or dermatomyositis 2001 ·Clinica Chimica Acta ·(unknown), Angelika Hammerer‐Lercher, Jürgen Falkensammer, (unknown), Samsonov MIu, (unknown), Bernd Puschendorf, Johannes Mair	67
16	Neopterin, soluble adhesion molecules and soluble cytokine receptors correlate with disease activity in rheumatoid arthritis 2000 ·Pteridines ·(unknown), Samsonov MIu, (unknown), (unknown), Bernhard Widner, Ulrike Demel, (unknown), Dietmar Fuchs	1
17	Serum-Soluble Receptors for Tumor Necrosis Factor-α and Interleukin-2, and Neopterin in Acute Rheumatic Fever 1995 ·Clinical Immunology and Immunopathology ·Samsonov MIu, Gernot P. Tilz, (unknown), Gilbert Reibnegger, E L Nassonov, V A Nassonova, H. Wächter, Dietmar Fuchs	24
18	Elevated Serum Neopterin Levels in Acute Rheumatic Fever 1993 ·Pteridines ·Samsonov MIu, Gilbert Reibnegger, E L Nassonov, V A Nassonova, H. Wächter, Dietmar Fuchs	2
19	Serum neopterin--possible immunological marker of myocardial inflammation in patients with dilated heart muscle disease 1991 ·European Heart Journal ·Samsonov MIu, E L Nassonov, Sawa Kostin, (unknown), (unknown), (unknown), (unknown), Mareev VIu, (unknown), (unknown)	9
20	Serum neopterin in dilated cardiomyopathy 1990 ·Terapevticheskii arkhiv ·(unknown), Samsonov MIu, (unknown), (unknown), (unknown), (unknown), (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact